quinoxalines has been researched along with cyclosporine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinemann, U; Müller, W; Schuchmann, S | 1 |
| Gu, Z; Jiang, Q; Jing, G; Zhang, G | 1 |
| Fonnum, F; Mariussen, E; Myhre, O; Reistad, T | 1 |
| Al-Katib, A; Dandashi, M; Mensah-Osman, E; Mohammad, R | 1 |
| Chow, VF; Clucas, AT; Gladue, RP; Shah, A; Zhang, YD | 1 |
| Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
| Liu, X; Wang, P; Wang, W; Xu, S | 1 |
| Butterton, JR; Caro, L; Fandozzi, CM; Feng, HP; Guo, Z; Iwamoto, M; Panebianco, D; Talaty, J; Wolford, D; Yeh, WW | 1 |
| Asatryan, A; Kort, J; Kosloski, MP; Li, H; Liu, W; Mensa, FJ; Pugatch, D; Zhao, W | 1 |
1 review(s) available for quinoxalines and cyclosporine
| Article | Year |
|---|---|
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
3 trial(s) available for quinoxalines and cyclosporine
| Article | Year |
|---|---|
Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cyclosporine; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Fasting; Half-Life; Humans; Male; Metabolic Clearance Rate; Molecular Structure; Quinoxalines; Receptors, CCR1; Receptors, Chemokine | 2007 |
Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Benzofurans; Cyclosporine; Drug Combinations; Drug Interactions; Female; Humans; Imidazoles; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Quinoxalines; Tacrolimus; Young Adult | 2018 |
Drug-Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Benzimidazoles; Cyclosporine; Drug Combinations; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Pyrrolidines; Quinoxalines; Sulfonamides; Tacrolimus; Young Adult | 2019 |
5 other study(ies) available for quinoxalines and cyclosporine
| Article | Year |
|---|---|
Altered Ca2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome.
Topics: Aging; Alzheimer Disease; Animals; Calcium; Carcinogens; Cell Death; Cyclosporine; Diploidy; Disease Models, Animal; Down Syndrome; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hippocampus; Karyotyping; Male; Membrane Potentials; Mice; Mice, Neurologic Mutants; Mitochondria; NADP; Neurons; Potassium; Quinoxalines; Signal Transduction; Trisomy; Vitamin E | 1998 |
N-methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apototic-like death.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclosporine; Dizocilpine Maleate; Egtazic Acid; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Glutamic Acid; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neurons; Nifedipine; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2000 |
The polychlorinated biphenyl mixture aroclor 1254 induces death of rat cerebellar granule cells: the involvement of the N-methyl-D-aspartate receptor and reactive oxygen species.
Topics: Animals; Cell Death; Cells, Cultured; Cerebellum; Chlorodiphenyl (54% Chlorine); Cyclosporine; Cytoplasmic Granules; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fatty Acids, Unsaturated; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Phosphodiesterase Inhibitors; Quinoxalines; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2002 |
XK469, a topo IIbeta inhibitor, induces apoptosis in Waldenstrom's macroglobulinemia through multiple pathways.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclosporine; Cytochromes c; Cytosol; Densitometry; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electron Transport Complex IV; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; Fluorometry; Humans; Ligands; Membrane Glycoproteins; Mitochondria; Models, Biological; Poly(ADP-ribose) Polymerases; Quinoxalines; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Up-Regulation; Waldenstrom Macroglobulinemia | 2003 |
Transient mitochondrial permeability transition mediates excitotoxicity in glutamate-sensitive NSC34D motor neuron-like cells.
Topics: Animals; Calcium Signaling; Cell Line, Transformed; Cyclosporine; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Hybrid Cells; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Motor Neurons; Oxidative Stress; Quinoxalines; Receptors, AMPA; Ruthenium Compounds; Time Factors; Transfection | 2015 |